FRONTIERS PROJECT
An Assessment of the Egyptian Norplant® Program

FRONTIERS worked with the Egypt Ministry of Health (MOH) and El Zanaty & Associates to assess the accuracy of management information on Norplant use. Researchers also investigated attitudes and knowledge about the implant among providers and users. About 17 percent of women had the implant removed before five years of use. Three-quarters of these women switched to another method. The most frequently reported side effects among discontinuers were severe bleeding, weight changes, and menstrual cycle disturbances. The majority of clients reported general satisfaction with Norplant.
 

---

Location

Egypt

Duration

July 2000–June 2001

Population Council researchers

Laila Nawar, Ramadan Hamed

Non-Council collaborators

Egypt Ministry of Health (MOH)

Fatma El Zanaty (El Zanaty & Associates)

Donor

US Agency for International Development

Publications/Resources
Council researchers' names appear in boldface type. 

2001
El Zanaty, Fatma, Laila Nawar, and Ramadan Hamed. "An assessment of selected sub-systems of the Egyptian Norplant® program," FRONTIERS Final Report. Washington, DC: Population Council. (PDF, 973 KB)

---

See Also

• Egypt
• Contraception
• Reproductive Health
• FRONTIERS Egypt
• FRONTIERS Contraception

---